IMATINIB (VEENAT) CAPSULE – TREATMENT FOR MULTIPLE CANCER
Tyrosine kinase inhibitors are a group of drugs that includes Veenat Capsule. It is used to treat gastrointestinal stromal tumors as well as two types of blood cancer: chronic myeloid leukemia and acute lymphocytic leukemia.
To receive the best benefit, Veenat Capsule should be taken with food at the same time each day. As long as your doctor recommends it, you should keep taking it. Depending on your needs and how you respond to treatment, the length of treatment varies.
USES OF IMATINIB (VEENAT) TABLET
- Blood cancer (Chronic myeloid leukemia)
- Blood cancer (Acute lymphocytic leukemia)
- Gastrointestinal stromal tumor
WORKS OF IMATINIB (VEENAT) TABLET
A drug used to treat cancer is called Veenat Capsule. Bcr-Abl tyrosine kinase is a protein enzyme that is in charge of the aberrant proliferation of cancer cells. In bar-all positive cells, this medication suppresses proliferation and causes apoptosis (planned cell death) (cancer cells). This is how the progression of cancer is slowed or stopped.
SIDE EFFECTS OF IMATINIB (VEENAT) TABLET
- Edema (swelling)
- Muscle cramp
- Musculoskeletal (bone, muscle, or joint) pain
- Abdominal pain
WARNING & PRECAUTIONS
Veenat Capsule’s adverse effects could impair your ability to operate a vehicle.
When taking Veenat Capsules, patients with kidney illness should exercise caution. Veenat Capsule dosage may need to be changed. Please speak with your physician.
When taking Veenat Capsules, people with severe liver disease should proceed with caution. Veenat Capsule dosage may need to be changed. Please speak with your physician.
Fedelty Health Care is an Imatinib third-party manufacturer, bulk pharma exporter, and pharmaceutical contract manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.